A clinical trial to study the effect of ayurvedic medicine jambuamrapallavadi vati in patients with excessive vomiting in pregnancy

A randomized controlled clinical study to evaluate the antiemetic effect of Jambuamrapallavadi vati over Eladi vati in management of garbhini chardi (emesis gravidarum). - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101726

Enrollment

Registered

2026-01-21

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O210- Mild hyperemesis gravidarum

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.patient diagnosed as Garbhini Chardi in first trimester of pregnancy. 2.Both Primigravida & multigravida, age group of patients between 22 to 30 years. 3.Patient complaining of nausea & vomiting less than 4 episode per day.

Exclusion criteria

Exclusion criteria: 1.patient with hyper emesis gravidarum more than 5 episodes per day. 2.vomiting caused due to other systemic disorder like Colonic Obstruction, Urinary tract infection, Renal calculi, Anemia, Jaundice Psychiatric illness, Enteric infection. 3.Patient with Thyroid dysfunction, Diabetes mellitus.

Design outcomes

Primary

Measure	Time frame
Vomiting is paused or reducedTimepoint: One month	—

Secondary

Measure	Time frame
No or reduced nausea & vomitingTimepoint: Two months	—

Countries

India

Contacts

Public ContactDr Sreeja V

Shree jagadguru gavisiddheshwara ayurvedic medical college, koppal

dr.sreejaarun@gmail.com8971432678

Outcome results